- Home
- DCGI
DCGI orders withdrawal of AstraZeneca’s cancer drug Olaparib for certain treatments
DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts
Drug controller’s nod for Omicron-specific mRNA-based vaccine
Zero tolerance on spurious medicines, 71 firms issued notices: Mandaviya on cough syrup row
Mandatory testing of cough syrup before exports, DCGI asks labs to give top priority to such samples
Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence
Deaths linked to cough syrups: Govt panel says info shared by WHO so far inadequate to determine aetiology
WHO alert on cough syrups ‘alarming’, there are missing links that need to be probed: Expert
Drug regulator’s nod sought for phase-3 study of intranasal Covid vaccine in 5-18 age group
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old
Covaxin gets DCGI nod for 6-12 age group, Corbevax approved for 5-12 bracket
Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease
DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group
DCGI grants restricted EUA for Covid jab Corbevax for 12-18 yrs age group
Serum Institute seeks DCGI’s approval for Covishield as booster dose
DCGI approves Bharat Biotech’s Covaxin for children in 2-18 age group
Zydus Cadila seeks emergency-use nod from DCGI for its Covid-19 vaccine
Cipla gets DCGI nod to import Moderna’s Covid-19 vaccine for restricted emergency use in India
Serum Institute of India applies to DCGI to manufacture Covid vaccine Sputnik V
Norms for clearing foreign-made Covid-19 vaccines eased by DCGI
Zydus Cadila seeks DCGI nod for human clinical trials of antibodies cocktail to treat COVID-19
DCGI approves Phase 2, 3 clinical trials of Bharat Biotech’s Covaxin for 2 -18 year-olds
Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin
DCGI gives nod for restricted emergency use of Russian COVID-19 vaccine Sputnik V in India: Sources
DCGI extends shelf life of Covishield from 6 to 9 months
Congress leaders raise concern over DCGI approval to indigenous Covid-19 vaccine
Zydus Cadila receives DCGI nod for NAFLD drug in India
Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1
DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial: Officials
Latest Additions
Varanasi court rejects Hindu side’s plea for survey through excavation in Gyanvapi complex
‘Do they get free power in UP, Haryana?’ Kejriwal asks people at rally
Nomination process ends for bypolls to 47 assembly seats in 13 states
Hard-working poor people robbed of dreams due to falling incomes, rising inflation: Rahul
Police book 7 ‘fake’ ED officers who ‘raided’ Delhi man, sought Rs 5 crore